Boehringer To Settle 3K Pradaxa Bleeding Risk Cases
Boehringer Ingelheim Pharmaceuticals Inc. told a Connecticut appeals court it has an agreement in principle to settle 2,935 lawsuits across the country over the bleeding risks of its blood thinner Pradaxa....To view the full article, register now.
Already a subscriber? Click here to view full article